QCLS insider filings
Q/C TECHNOLOGIES, INC. — 24 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-20. Screen QCLS transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 4 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Silverman Joshua — Executive Chairman, Director | 2 | — | — | 4 |
| PharmaCyte Biotech, Inc. — 10% owner | 1 | — | — | 3 |
| Ehrlichman Yossef — Chief Technology Officer | 1 | — | — | — |
Recent insider filings — Q/C TECHNOLOGIES, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | PharmaCyte Biotech, Inc. — 10% owner | Option exercise/expiry (X): 4,982,272 @ $0 · Option exercise/expiry (X): 851,304 (derivative) @ $0 · Other (J): 3,000 (derivative) @ $0 | EDGAR |
| 2026-10-02 | 4/A | Silverman Joshua — Executive Chairman, Director | Grant/award (A): 16,806 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-10-02 | 4 | Silverman Joshua — Executive Chairman, Director | Grant/award (A): 16,620 @ $0 · Grant/award (A): 77,390 @ $0 | EDGAR |
| 2026-09-22 | 3 | Ehrlichman Yossef — Chief Technology Officer | Holdings only — no transactions reported | EDGAR |
| 2026-05-14 | 4 | Voss Chelsea Sierra — Director | Purchase (P): 1,753 @ $3.15 | EDGAR |
| 2026-04-15 | 4 | White Billy Joe — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Voss Chelsea Sierra — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Silverman Joshua — Executive Chairman, Director | Grant/award (A): 162,162 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Glass Mitchell — Chief Medical Officer, Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Friscia Stephen — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Bernstein Bruce — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Voss Chelsea Sierra — Director | Grant/award (A): 212,500 @ $0 · Grant/award (A): 25,000 @ $0 · Grant/award (A): 212,500 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | PharmaCyte Biotech, Inc. — 10% owner | Purchase (P): 889,865 (derivative) · Purchase (P): 889,865 (derivative) | EDGAR |
| 2025-11-17 | 4 | Glass Mitchell — Director, Chief Medical Off., Director | Grant/award (A): 11,420 @ $0 | EDGAR |
| 2025-11-17 | 4 | White Billy Joe — Director | Grant/award (A): 22,839 @ $0 | EDGAR |
| 2025-11-14 | 4 | Silverman Joshua — Executive Chairman, Director | Grant/award (A): 91,356 @ $0 | EDGAR |
| 2025-11-14 | 4 | Friscia Stephen — Director | Grant/award (A): 22,839 @ $0 | EDGAR |
| 2025-11-14 | 4 | Bernstein Bruce — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2025-11-14 | 4 | RAUCH GARY M | Grant/award (A): 11,420 @ $0 | EDGAR |
| 2025-10-06 | 4 | White Billy Joe — Director | Grant/award (A): 2,161 @ $0 | EDGAR |
| 2025-10-06 | 4 | Silverman Joshua — Executive Chairman, Director | Grant/award (A): 8,644 @ $0 | EDGAR |
| 2025-10-06 | 4 | RAUCH GARY M | Grant/award (A): 1,080 @ $0 | EDGAR |
| 2025-10-06 | 4 | Glass Mitchell — Director, Chief Medical Off., Director | Grant/award (A): 1,080 @ $0 | EDGAR |
| 2025-10-06 | 4 | Friscia Stephen — Director | Grant/award (A): 2,161 @ $0 | EDGAR |
Recent 8-K events — Q/C TECHNOLOGIES, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-13 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-09-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-11 | 8-K | 1.02 — Termination of a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 1.02 — Termination of a Material Definitive Agreement 8.01 — Other Events | EDGAR |
| 2026-03-13 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-06 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=QCLS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs